<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) are considered pre-<z:mp ids='MP_0002055'>diabetes</z:mp> states </plain></SENT>
<SENT sid="1" pm="."><plain>There are limited data in pediatrics in regard to their pathophysiology </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated differences in insulin sensitivity and secretion among youth with IFG, IGT, and coexistent IFG/IGT compared with those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 24 <z:mp ids='MP_0001261'>obese</z:mp> adolescents with NGT, 13 with IFG, 29 with IGT, 11 with combined IFG/IGT, and 30 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> underwent evaluation of hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production ([6,6-(2)H(2)]<z:chebi fb="105" ids="17234">glucose</z:chebi>), insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal (R(d), euglycemic clamp), first- and second-phase insulin secretion (hyperglycemic clamp), body composition (dual-energy X-ray absorptiometry), abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> (computed tomography), and substrate oxidation (indirect calorimetry) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Adolescents with NGT, pre-<z:mp ids='MP_0002055'>diabetes</z:mp>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had similar body composition and abdominal fat distribution </plain></SENT>
<SENT sid="5" pm="."><plain>R(d) was lower (P = 0.009) in adolescents with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than in those with NGT </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with adolescents with NGT, first-phase insulin was lower in those with IFG, IGT, and IFG/IGT with further deterioration in those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P &lt; 0.001), and Î²-cell function relative to insulin sensitivity (<z:chebi fb="105" ids="17234">glucose</z:chebi> disposition index [GDI]) was also lower in those with IFG, IGT, and IFG/IGT (40, 47, and 47%, respectively), with a further decrease (80%) in those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>GDI was the major determinant of fasting and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> levels </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:mp ids='MP_0001261'>Obese</z:mp> adolescents who show signs of <z:chebi fb="105" ids="17234">glucose</z:chebi> dysregulation, including abnormal fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> or both, are more likely to have <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> rather than reduced insulin sensitivity </plain></SENT>
<SENT sid="9" pm="."><plain>Given the impairment in insulin secretion, they are at high risk for progression to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Further deterioration in insulin sensitivity or secretion may enhance the risk for this progression </plain></SENT>
</text></document>